Athira Pharma's net tangible assets is $34M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Athira Pharma (ATHA) currently reports a net tangible assets of $34M as of June 2026. That compares with $32M in the prior-year period — up 5.0% year over year. Use the charts on this page to explore Athira Pharma's net tangible assets history and peer comparisons.
Athira Pharma's net tangible assets increased from $32M to $34M — a 5.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Athira Pharma reported $34M in net tangible assets as of June 2026. That compares with $32M in the prior-year period — up 5.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current net tangible assets of $34M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Athira Pharma, and consider following ATHA for alerts when major investors trade the stock.
Athira Pharma is classified in the Healthcare sector. On net tangible assets, it currently shows $34M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ATHA with unrelated industries.